Doyle Mittie
Chief Medical Officer
3 filings on record here, covering AVTX. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Exercise | AVTX | Avalo Therapeutics, Inc. | $5,459 |
| Sell | AVTX | Avalo Therapeutics, Inc. | $13,580 |
| Exercise | AVTX | Avalo Therapeutics, Inc. | |
CORPORATEFiled 2026-07-29
| Exercise | AVTX | Avalo Therapeutics, Inc. | $12,650 |
| Sell | AVTX | Avalo Therapeutics, Inc. | $20,000 |
| Exercise | AVTX | Avalo Therapeutics, Inc. | |
CORPORATEFiled 2026-06-25
| Exercise | AVTX | Avalo Therapeutics, Inc. | $11,658 |
| Sell | AVTX | Avalo Therapeutics, Inc. | $26,100 |
| Exercise | AVTX | Avalo Therapeutics, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.